Literature DB >> 22591371

Mechanism(s) involved in opioid drug abuse modulation of HAND.

Raini Dutta1, Sabita Roy.   

Abstract

Drug abuse and HIV infection are interlinked. From the onset of the HIV/AIDS epidemic, the impact of illicit drug use on HIV disease progression has been a focus of many investigations. Both laboratory-based and epidemiological studies strongly indicate that drug abuse may exacerbate HIV disease progression and increase mortality and morbidity in these patients. Increase susceptibility to opportunistic infection has been implicated as one of the major causes for this detriment. Furthermore, opioids are known to elicit prevalence of neurodegenerative disorders in HIV-infected patients. Numerous authors have delineated various molecular as well as cellular mechanisms associated with neurological complications in these patients. This review gives an overview of these findings. Understanding the mechanisms will allow for the development of targeted therapies aimed at reducing the progression of neurocognitive decline in the drug abusing HIV infected individuals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22591371      PMCID: PMC3565579          DOI: 10.2174/157016212802138805

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  100 in total

1.  Abuse of prescription drugs and the risk of addiction.

Authors:  Wilson M Compton; Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2006-03-23       Impact factor: 4.492

2.  The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis.

Authors:  M Murray; R S Hogg; V D Lima; M T May; D M Moore; S Abgrall; M Bruyand; A D'Arminio Monforte; C Tural; M J Gill; R J Harris; P Reiss; A Justice; O Kirk; M Saag; C J Smith; R Weber; J Rockstroh; P Khaykin; J A C Sterne
Journal:  HIV Med       Date:  2011-08-07       Impact factor: 3.180

3.  Detection of HHV-6B in post-mortem central nervous system tissue of a post-bone marrow transplant recipient: a multi-virus array analysis.

Authors:  Karen Yao; Nahid Akyani; Donatella Donati; Naomi Sengamalay; Julie Fotheringham; Elodie Ghedin; Michael Bishop; John Barrett; Fatah Kashanchi; Steven Jacobson
Journal:  J Clin Virol       Date:  2006-12       Impact factor: 3.168

4.  AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines.

Authors:  G J Nuovo; M L Alfieri
Journal:  Mol Med       Date:  1996-05       Impact factor: 6.354

5.  Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes.

Authors:  Xu Wang; Li Ye; Yu Zhou; Man-Qing Liu; Dun-Jin Zhou; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

6.  Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection.

Authors:  J B Rottman; K P Ganley; K Williams; L Wu; C R Mackay; D J Ringler
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

Review 7.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

8.  Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Jessica L Reynolds; Bindukumar B Nair; Stanley F Fernandez; Stanley A Schwartz; Madhavan P N Nair
Journal:  Curr HIV Res       Date:  2005-07       Impact factor: 1.581

9.  Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication.

Authors:  Amber D Steele; Earl E Henderson; Thomas J Rogers
Journal:  Virology       Date:  2003-04-25       Impact factor: 3.616

10.  Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy.

Authors:  F Gyorkey; J L Melnick; P Gyorkey
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

View more
  20 in total

1.  Frontline Science: Buprenorphine decreases CCL2-mediated migration of CD14+ CD16+ monocytes.

Authors:  Matias Jaureguiberry-Bravo; Lillie Lopez; Joan W Berman
Journal:  J Leukoc Biol       Date:  2018-05-23       Impact factor: 4.962

2.  HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.

Authors:  Crystal R Leibrand; Jason J Paris; Austin M Jones; Quamrun N Masuda; Matthew S Halquist; Woong-Ki Kim; Pamela E Knapp; Angela D M Kashuba; Kurt F Hauser; MaryPeace McRae
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

3.  Latest trends in drugs of abuse - HIV infection and neuroAIDS.

Authors:  Sneham Tiwari; Madhavan Pn Nair; Shailendra K Saxena
Journal:  Future Virol       Date:  2013-02       Impact factor: 1.831

Review 4.  Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.

Authors:  Alexander J Gill; Dennis L Kolson
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

5.  Effect of chronic morphine administration on circulating dendritic cells in SIV-infected rhesus macaques.

Authors:  William D Cornwell; Wendeline Wagner; Mark G Lewis; Xiaoxuan Fan; Jay Rappaport; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2016-04-16       Impact factor: 3.478

Review 6.  Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders.

Authors:  Bradley Nash; Lindsay Festa; Chihyang Lin; Olimpia Meucci
Journal:  Brain Res       Date:  2019-08-26       Impact factor: 3.252

7.  Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users.

Authors:  Donald B Smith; Peter Simmonds; Jeanne E Bell
Journal:  J Neurovirol       Date:  2014-01-14       Impact factor: 2.643

Review 8.  Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.

Authors:  Kurt F Hauser; Pamela E Knapp
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

9.  Cell-type specific differences in antiretroviral penetration and the effects of HIV-1 Tat and morphine among primary human brain endothelial cells, astrocytes, pericytes, and microglia.

Authors:  Sulay H Patel; Omnia A Ismaiel; William R Mylott; Moucun Yuan; Joseph L McClay; Jason J Paris; Kurt F Hauser; MaryPeace McRae
Journal:  Neurosci Lett       Date:  2019-09-03       Impact factor: 3.046

10.  Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis.

Authors:  Monica Bawor; Brittany B Dennis; Anuja Bhalerao; Carolyn Plater; Andrew Worster; Michael Varenbut; Jeff Daiter; David C Marsh; Dipika Desai; Meir Steiner; Rebecca Anglin; Guillaume Pare; Lehana Thabane; Zainab Samaan
Journal:  CMAJ Open       Date:  2015-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.